TVGN
Tevogen Bio Holdings Inc - TVGN 116项目未来5年累计营收预测约65亿美元
时间:2025-09-10 03:18:22 市场: 美股 综合
Tevogen Bio Meets Barda Techwatch Team, Highlighting Exactcell™ Technology’s Potential as a Scalable Medical Countermeasure
时间:2025-02-08 03:56:57 市场: 美股 综合
Tevogen Bio Enters Agreement to Receive up to $10 Million of Non-Dilutive Grant Funding
时间:2025-01-29 04:49:48 市场: 美股 综合
Tevogen Bio Shares up 28% After Co to Expand Microsoft AI Collaboration
时间:2025-01-27 22:32:26 市场: 美股 综合
Tevogen Bio Shares Rise 60% at $2.16 Premarket After Co to Broaden AI Collaboration With Microsoft
时间:2025-01-27 17:50:29 市场: 美股 综合
Tevogen Bio Broadens Relationship With Microsoft to Deepen Artificial Intelligence Collaboration and Develop Predictcell Technology on Azure
时间:2025-01-25 06:34:26 市场: 美股 综合
Tevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued Operations
时间:2024-11-09 04:36:48 市场: 美股 综合
Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI Into Preclinical Processes, Accelerating Drug Development and Reducing Costs
时间:2024-10-31 22:54:56 市场: 综合 美股
Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company
时间:2024-10-30 03:28:32 市场: 美股 综合
Tevogen Bio Signs Letter of Intent With Cd8 Technology to Build up to a $50 Million R&D and Manufacturing Facility; No Impact on Shareholder Equity
时间:2024-10-30 00:43:39 市场: 美股 综合